Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
6.43B | 6.78B | 6.29B | 5.93B | 4.00B | Gross Profit |
2.46B | 1.80B | 1.54B | 1.58B | 1.09B | EBIT |
-562.00M | -637.00M | -822.00M | -1.09B | -651.00M | EBITDA |
7.78B | 5.30B | 9.90B | 659.00M | 97.00M | Net Income Common Stockholders |
2.85B | 4.33B | 12.22B | 5.30B | 3.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
19.26B | 21.28B | 13.66B | 6.46B | 8.36B | Total Assets |
62.27B | 65.50B | 71.32B | 53.82B | 36.32B | Total Debt |
16.50B | 16.34B | 16.19B | 8.20B | 3.82B | Net Debt |
14.68B | 14.93B | 14.74B | 6.90B | 2.90B | Total Liabilities |
20.99B | 20.89B | 21.19B | 12.96B | 6.39B | Stockholders Equity |
17.87B | 18.96B | 20.58B | 29.19B | 21.75B |
Cash Flow | Free Cash Flow | |||
936.00M | -479.00M | -981.00M | -68.00M | -310.00M | Operating Cash Flow |
1.03B | -177.00M | -702.00M | 73.00M | -196.00M | Investing Cash Flow |
142.00M | 12.62B | 6.05B | -678.00M | 2.44B | Financing Cash Flow |
-8.24B | -12.16B | 754.00M | 53.00M | -121.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $63.09B | 15.79 | 22.60% | 2.42% | 0.23% | -0.09% | |
78 Outperform | $67.31B | 11.18 | 17.55% | 1.77% | 5.20% | 77.60% | |
78 Outperform | $172.71B | 11.78 | 45.06% | ― | 57.51% | 82.28% | |
76 Outperform | $34.31B | 10.53 | 9.37% | ― | -2.60% | 19.69% | |
67 Neutral | $42.16B | 13.53 | 17.75% | 0.19% | 11.37% | ― | |
61 Neutral | $1.13B | 8.39 | 8.94% | ― | -13.37% | -44.13% | |
59 Neutral | $28.05B | 1.00 | -21.89% | 4.05% | 2.23% | -51.39% |